financetom
Business
financetom
/
Business
/
US regulator, financial industry monitoring impact of Hurricane Milton on investors, capital markets
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US regulator, financial industry monitoring impact of Hurricane Milton on investors, capital markets
Oct 9, 2024 10:10 AM

NEW YORK/WASHINGTON (Reuters) - The Securities and Exchange Commission and a top financial industry group said they were closely monitoring the impact of Hurricane Milton on investors and capital markets.

The SEC said in a statement on Wednesday it would consider possible relief from regulatory requirements for those affected by the storm.

The Securities Industry and Financial Markets Association (SIFMA) said in a separate statement it was confident its member firms in Florida were prepared for the storm.

The SEC, which oversees companies, accountants, investment advisers and other financial professionals, will continue to track developments and consider granting relief from filing deadlines and other regulatory requirements for those affected by the storms. The agency added it continued to monitor the prior impact of Hurricane Helene, which devastated other parts of the United States, including North Carolina.

SIFMA Managing Director Stephen Byron said in the statement that the group frequently works with its members on a range of contingency planning exercises, including hurricanes. The group is also in contact with relevant government agencies, he added.

"Our business continuity planning efforts and exercises, which are broadly participated in by our member firms, are designed to prepare the industry to the extent possible for major events such as this one," he said.

"We are in contact with our member firms who are geographically located in Florida and have a high degree of confidence in their and the broader industry's ability to prepare for, respond to and recover from emergencies."

(Reporting by Chris Prentice and Pete Schroeder; Editing by Emelia Sithole-Matarise)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved